US20230271985A1

US20230271985A1 - Preparation method for glufosinate

Info

Publication number: US20230271985A1
Application number: US18/312,088
Authority: US
Inventors: Yongjiang LIU; Lei Zhou; Wei Zeng; Min Xu; Ke Cheng; Yingsui Yin
Original assignee: Lier Chemical Co Ltd; Guangan Lier Chemical Co Ltd
Current assignee: Lier Chemical Co Ltd; Guangan Lier Chemical Co Ltd
Priority date: 2020-01-20
Filing date: 2023-05-04
Publication date: 2023-08-31
Also published as: BR112022008792B1; CA3157884A1; US20220259232A1; KR20220113365A; AU2021209728B2; IL292593A; MX2022005442A; KR102515430B1; JP2022551341A; CA3157884C; AU2021209728A1; IL292593B1; IL292593B2; US11680077B2; BR112022008792A2; CN113490671B; EP4043468A1; WO2021147894A1; CN113490671A; JP2024023340A

Abstract

A preparation method for glufosinate ammonium or a salt thereof, an enantiomer thereof, or mixtures of the enantiomer thereof in all ratios, comprising reacting a compound of formula (II) or a salt, an enantiomer, or mixtures of the enantiomer in all ratios with one or more compounds of formula (III) or mixtures thereof.

Description

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 17/610,051, which was the National Stage of International Application No. PCT/CN2021/072854, filed Jan. 20, 2021, which claims the benefit of Chinese Application No. 202010064268.7, filed Jan. 20, 2020. The entirety of these prior applications is incorporated by reference herein.

FIELD OF THE INVENTION

The present invention relates to a preparation method for glufosinate.

BACKGROUND OF THE INVENTION

Glufosinate is an important herbicide.

SUMMARY OF THE INVENTION

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides a method for preparing glufosinate of formula (I) or a salt, an enantiomer thereof or a mixture of the enantiomers in all ratios, comprising the following steps:

- a) reacting a compound of formula (II) or a salt, an enantiomer thereof or a mixture of the enantiomers in all ratios,

- with one or more compounds of formula (III) or a mixture;
- the above mixture being a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (V); or a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (V) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V);

- b) reacting the intermediate, no matter whether it is isolated or not, in the presence of water and an acid or a base to obtain the glufosinate (I) or a salt, an enantiomer thereof or a mixture of the enantiomers in all ratios;
- wherein when PG is an amino protecting group, a step of removing the amino protecting group can be further comprised;
- wherein Hal¹and Hal²are each independently halogen; PG is hydrogen or an amino protecting group; R₁, R₂, R₃and R₄are each independently alkyl, phenyl or substituted phenyl, and when the mixture comprises the mixture of one or more compounds of formula (IV) and one or more compounds of formula (III), or when the mixture comprises the mixture of one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V), R₂is either R₃or R₄; and the chiral carbon atom is labeled with *.

The present invention further provides a method for preparing enantiomerically pure glufosinate of formula (I) or a salt thereof,

- the method comprises the following steps:
- a1) reacting an enantiomerically pure compound of formula (II) or a salt thereof,

- with a compound of formula (III),

- or one or more compounds of formula (III) or a mixture;
- the above mixture being a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (V); or a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (V) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V);

- b1) reacting the intermediate, no matter whether it is isolated or not, in the presence of water and an acid or a base to obtain the enantiomerically pure glufosinate (I) or a salt thereof;
- wherein when PG is an amino protecting group, a step of removing the amino protecting group can be further comprised;
- wherein Hal¹and Hal²are each independently halogen; PG is hydrogen or an amino protecting group; R₁, R₂, R₃and R₄are each independently alkyl, phenyl or substituted phenyl, and when the mixture comprises the mixture of one or more compounds of formula (IV) and one or more compounds of formula (III), or when the mixture comprises the mixture of one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V), R₂is either R₃or R₄; and the chiral carbon atom is labeled with *.

In certain specific embodiments, one compound of formula (III), e.g., chloro(ethoxy)(methyl)phosphane, is employed.
In certain specific embodiments, a mixture of one compound of formula (IV) and one compound of formula (V) is employed, such as a mixture of dichloro(methyl)phosphane and diethyl methylphosphonite, and the mixture can be further added with a compound of formula (III), e.g., chloro(ethoxy)(methyl)phosphane, in any ratio.
Further, the enantiomeric ratio is (L):(D)-enantiomer or (D):(L)-enantiomer of 50.5:49.5 to 99.5:0.5.
Further, the enantiomeric ratio is (L):(D)-enantiomer of 50.5:49.5 to 99.5:0.5.
Further, the PG is hydrogen.
Further, the Hal¹is a chlorine atom.
Further, the Hal²is a chlorine atom.
Further, the R₁, R₂, R₃and R₄are each independently C₁-C₆alkyl, preferably C₁-C₄alkyl.
Further, the R₁is ethyl.
Further, the R₂is ethyl.
Further, the R₃is ethyl.
Further, the R₄is ethyl.
In certain specific embodiments, the mixture is a mixture of one or more compounds of formula (IV) and one or more compounds of formula (III), and the molar ratio of the compounds of formula (IV) to the compounds of formula (III) is (0.9-1.1):1 or (0.05-1.1):1; or the mixture is a mixture of one or more compounds of formula (V) and one or more compounds of formula (III), and the molar ratio of the compounds of formula (V) to the compounds of formula (III) is (0.9-1.1):1 or (0.05-1.1):1; or the mixture is a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (V), and the molar ratio of the compounds of formula (IV) to the compounds of formula (V) is (0.9-1.1):1.
Further, in aforementioned step a) or a1), the reaction can proceed at room temperature, the reaction temperature can be 20-200° C., and preferably 90-140° C. in consideration of reaction efficiency.
Further, the aforementioned step a) or a1) is carried out in the presence of a base.
Further, the base in aforementioned step a) or a1) is an organic base or ammonia.
Further, in aforementioned step a) or a1), the organic base is selected from the group consisting of an organic amine, pyridine or a pyridine derivative having 1-3 substituents attached to one or more carbon atoms in the heterocycle, piperidine or a piperidine derivative having 1-3 substituents attached to one or more carbon atoms in the heterocycle.
Further, the organic base is selected from the group consisting of triethylamine, piperidine or pyridine.
Further, in aforementioned step a) or a1), the molar ratio of the base to the total amounts of the compound of formula (III) and the compound of formula (V) is (1-10):1.
Further, in aforementioned step a) or a1), the reaction is carried out under a solvent-free condition or in an inert solvent.
Further, in aforementioned step a) or a1), the inert solvent is selected from any one or more of benzene solvents, amide solvents, hydrocarbon solvents, halogenated hydrocarbon solvents, sulfone or sulfoxide solvents, ether solvents or ester solvents; preferably, the inert solvent is selected from any one or more of benzene solvents, amide solvents, halogenated hydrocarbon solvents, ether solvents or ester solvents.
Further, in aforementioned step a) or a1), the inert solvent is selected from any one or more of chlorobenzene, trimethylbenzene, 1,4-dioxane, 1,2-dichloroethane, dimethyl sulfoxide, N-methylpyrrolidone, N,N-dimethylformamide, petroleum ether, n-heptane, tetrahydrofuran, methyltetrahydrofuran, benzene, toluene, ethyl acetate, and butyl acetate.
Further, in aforementioned step a) or a1), the molar ratio of the compound of formula (III) or the mixture to the compound of formula (II) is 1:(0.8-10), preferably 1:(1-3); or the molar ratio of the compound of formula (II) to the compound of formula (III) or the mixture is 1:(0.8-10), preferably 1:(1-3).
Further, in aforementioned step b) or b1), an inorganic acid or an organic acid is added.
Further, the inorganic acid is hydrochloric acid or sulfuric acid.
Further, in aforementioned step b) or b1), the base is an inorganic base or an organic base.
Further, the base is alkali metal hydroxide, alkali-earth metal hydroxide, alkali metal carbonate, alkali-earth metal carbonate, alkali metal bicarbonate or alkali-earth metal bicarbonate.
Further, the base is NaOH, KOH or Ba(OH)₂.
Further, in aforementioned step b) or b1), the reaction temperature is 20-150° C.
As a specific embodiment, a compound of formula (IIa) is reacted with a compound of formula (IIIa),

- and an acid (e.g., hydrochloric acid) is then added to obtain L-glufosinate.

The present invention further provides a compound of formula (III)

- wherein Hal²and R₂are as defined above.

The present invention further provides use of the compound of formula (III), particularly a compound of formula (IIIa), in the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof,
The present invention further provides a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (V); or a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (V) and one or more compounds of formula (III); or a mixture comprising one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V);

- wherein Hal², R₂, R₃and R₄are as defined above.

Further, the above mixture is a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (V), and the molar ratio of the compounds of formula (IV) to the compounds of formula (V) is (0.9-1.1):1; or the mixture is a mixture comprising one or more compounds of formula (IV) and one or more compounds of formula (III), and the molar ratio of the compounds of formula (IV) to the compounds of formula (III) is (0.9-1.1):1 or (0.05-1.1):1; or the mixture is a mixture comprising one or more compounds of formula (V) and one or more compounds of formula (III), and the molar ratio of the compounds of formula (V) to the compounds of formula (III) is (0.9-1.1):1 or (0.05-1.1):1.
Further, the compound of formula (IV) is diethyl methylphosphonite, and the compound of formula (V) is dichloro(methyl)phosphane.
The present invention further provides use of the aforementioned mixture in the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof.
The method of the present invention is particularly suitable for the preparation of glufosinate, and substantially reduces the steps of the existing preparation processes. In particular, in the preparation of L-glufosinate, the product can effectively maintain the ee value of the raw material. For example, when an enantiomeric ally pure raw material (e.g., the enantiomeric excess percentage (% ee) is greater than 90%) is employed, the enantiomeric excess percentage (% ee) of the prepared L-glufosinate is greater than e.g., 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%.
Unless otherwise specified, the terms used in the specification and claims have the following meanings.
The term “amino protecting group” refers to a group that can be attached to a nitrogen atom in an amino group to protect the amino group from participating the reaction and can be easily removed in the subsequent reactions. Suitable amino protecting groups include, but are not limited to, the following protecting groups:

- carbamate group of formula —C(O)O—R, wherein R is methyl, ethyl, tert-butyl, benzyl, phenethyl, CH₂═CH—CH₂—, etc.; amide group of formula —C(O)—R′, wherein R′ is methyl, ethyl, phenyl, trifluoromethyl, etc.; N-sulfonyl derivative group of formula —SO₂—R″, wherein R″ is tolyl, phenyl, trifluoromethyl, 2,2,5,7,8-pentamethylchroman-6-yl-, 2,3,6-trimethyl-4-methoxybenzene, etc.

The term “alkyl” refers to a saturated aliphatic hydrocarbon group, including linear and branched groups having 1 to 18 carbon atoms. Alkyl having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl and pentyl, is preferred. The alkyl can be substituted or unsubstituted, and when substituted, the substituent can be halogen, nitro, sulfonyl, ether oxy, ether thio, ester, thioester or cyano.
The C₁-C₄alkyl is linear or branched, comprising saturated hydrocarbon chain having 1 to 4 carbon atoms. It can be methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl or tert-butyl.
The “mixture of the enantiomers in all ratios” as used herein has the same meaning as the “mixture of the enantiomers in any ratio”.

Mode of Carrying Out the Invention

Preparation of Compound 1

10 g of L-homoserine lactone hydrochloride (ee value of 99%, 137.56 g/mol, 0.073 mol) was weighed into a reaction flask, and 50 mL of ethanol (46.07 g/mol, 0.886 mol, 0.816 g/mL) was added (the molar ratio of homoserine lactone hydrochloride to ethanol is 1:12.1). The system was cooled to 10° C., and 21.7 g of thionyl chloride (118.97 g/mol, 0.182 mol) was slowly dropwise added (the molar ratio of L-homoserine lactone hydrochloride to thionyl chloride is 1:2.5). The system temperature was maintained at 10° C., and stirred for 30 minutes. The reaction was heated to 35° C., and stirred for 20 h, during which bubbles were continuously generated. The reaction was monitored by LC-MS. The reaction was stopped, the system was cooled to room temperature, and the remaining thionyl chloride and ethanol were distilled off under reduced pressure. The solid residue was slurried with 30 mL of n-hexane/ethyl acetate mixed solvents (the volume ratio of n-hexane to ethyl acetate is 2:1), filtered and dried to obtain 13.69 g of chloro-homoserine ethyl ester hydrochloride (202.08 g/mol, 0.0657 mol), wherein the HPLC purity is 97%, and the yield calculated on the basis of the amount of the reactant L-homoserine lactone hydrochloride is 90%.
The chloro-homoserine ethyl ester hydrochloride solid was reacted with a saturated sodium carbonate solution. The system was adjusted to a pH of 7-8, and extracted with ethyl acetate for 3 times, wherein the amounts of ethyl acetate in the 3 extraction processes were 30 mL, 10 mL and 10 mL, respectively. The organic phases were collected, and concentrated to obtain 10.30 g of the oily target product, chloro-homoserine ethyl ester (165.62 g/mol, 0.0591 mol), wherein the HPLC purity was 95%, the ee value was 99%, and the yield calculated based on the intermediate product chloro-homoserine ethyl ester hydrochloride was 90%.
MS (ESI): m/z [M+H]⁺ calculated for C6H13ClNO2: 166.06, found: 166.0.
¹H NMR (CDCl₃, 400 MHz) δ: 4.04 (q, J=7.1 Hz, 2H), 3.65-3.50 (m, 2H), 3.48 (dd, J=9.0, 4.7 Hz, 1H), 2.05 (dddd, J=14.7, 8.5, 6.4, 4.6 Hz, 1H), 1.87-1.64 (m, 3H), 1.13 (t, J=7.2 Hz, 3H).
¹³C NMR (CDCl₃, 100 MHz) δ: 175.3, 61.0, 51.6, 41.5, 37.0, 14.1.

Example 1

Under a nitrogen atmosphere, diethyl methylphosphonite (65.9 g, 484.8 mmol, 1.0 eq) and a solvent 1,4-dioxane (66 g) were added to a round-bottom flask, a 1,4-dioxane (63 g) solution of dichloro(methyl)phosphane (62.3 g, 533.3 mmol, 1.1 eq) were dropwise added through a constant-pressure funnel, and the reaction was stirred at room temperature overnight. 1,4-dioxane and chloro(ethoxy)(methyl)phosphane (colorless liquid, 85.8 g, yield: 70%) were distilled out under reduced pressure.
¹H NMR (D₂O, 43 MHz) δ: 3.92-2.96 (m, 2H), 1.31 (d, J=12.8 Hz, 3H), 0.84 (t, J=7.0 Hz, 3H).

Example 2

Under a nitrogen atmosphere, compound 1 (40.0 g, 242.4 mmol, 1.0 eq), chlorobenzene (81.9 g, 727.2 mmol, 3.0 eq) and triethylamine (29.4 g, 290.9 mmol, 1.2 eq) were respectively added to a three-neck flask, chloro(ethoxy)(methyl)phosphane (36.8 g, 290.9 mmol, 1.2 eq) was dropwise added, and the reaction was stirred at room temperature for 2 hours. The reaction was heated to 100° C., and allowed to proceed for 20 h. MS detection indicated that the raw material disappeared. The reaction was cooled to room temperature, dropwise added with 36% HCl (294.9 mL, 3432.6 mmol, 14.0 eq), and heated to reflux until complete reaction of the starting material. The solvent was evaporated, 95% ethanol (200 mL) and water (20 mL) were added, and the mixture was heated to reflux until the product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain L-glufosinate (white crystal, 38.4 g, yield: 88%, 98% ee).
MS (ESI): m/z [M+H]⁺ calculated for C5H13NO4P: 182.05, found 182.1.
¹H NMR (D₂O, 400 MHz) δ: 4.08 (t, J=6.2 Hz, 1H), 2.11 (dddd, J=14.6, 11.0, 8.7, 6.0 Hz, 2H), 1.99-1.73 (m, 2H), 1.44 (d, J=14.2 Hz, 3H).
¹³C NMR (D₂O, 100 MHz) δ: 171.0, 52.8, 52.6, 25.5, 24.6, 22.6, 22.5, 13.9, 13.0.
³¹P NMR (D₂O, 160 MHz) δ: 53.8.
Example 3
Under a nitrogen atmosphere, compound 1 (40.0 g, 242.4 mmol, 1.0 eq), chlorobenzene (81.9 g, 727.2 mmol, 3.0 eq) and pyridine (23.0 g, 290.9 mmol, 1.2 eq) were respectively added to a three-neck flask, chloro(ethoxy)(methyl)phosphane (36.8 g, 290.9 mmol, 1.2 eq) was dropwise added, and the reaction was stirred at room temperature for 2 hours. The reaction was heated to 100° C., and allowed to proceed for 20 h. MS detection indicated that the raw material disappeared. The reaction was cooled to room temperature, dropwise added with 36% HCl (294.9 mL, 3432.6 mmol, 14.0 eq), and heated to reflux until complete reaction of the starting material. The solvent was evaporated, 95% ethanol (200 mL) and water (20 mL) were added, and the mixture was heated to reflux until the product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain L-glufosinate (white crystal, 35.3 g, yield: 81%, 96% ee).

Example 4

Under a nitrogen atmosphere, compound 1 (40.0 g, 242.4 mmol, 1.0 eq), chlorobenzene (81.9 g, 727.2 mmol, 3.0 eq) and piperidine (24.8 g, 290.9 mmol, 1.2 eq) were respectively added to a three-neck flask, chloro(ethoxy)(methyl)phosphane (36.8 g, 290.9 mmol, 1.2 eq) was dropwise added, and the reaction was stirred at room temperature for 2 hours. The reaction was heated to 100° C., and allowed to proceed for 20 h. MS detection indicated that the raw material disappeared. The reaction was cooled to room temperature, dropwise added with 36% HCl (294.9 mL, 3432.6 mmol, 14.0 eq), and heated to reflux until complete reaction of the starting material. The solvent was evaporated, 95% ethanol (200 mL) and water (20 mL) were added, and the mixture was heated to reflux until the product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain L-glufosinate (white crystal, 33.2 g, yield: 76%, 94% ee).

Example 5

Under a nitrogen atmosphere, compound 1 (40.0 g, 242.4 mmol, 1.0 eq) and chlorobenzene (81.9 g, 727.2 mmol, 3.0 eq) were respectively added to a three-neck flask. Chloro(ethoxy)(methyl)phosphane (36.8 g, 290.9 mmol, 1.2 eq) was dropwise added, and ammonia was simultaneously bubbled in until saturation. The reaction was stirred at room temperature for 2 hours. The reaction was heated to 100° C., and allowed to proceed for 20 h. MS detection indicated that the raw material disappeared. The reaction was cooled to room temperature, dropwise added with 36% HCl (294.9 mL, 3432.6 mmol, 14.0 eq), and heated to reflux until complete reaction of the starting material. The solvent was evaporated, 95% ethanol (200 mL) and water (20 mL) were added, and the mixture was heated to reflux until the product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain L-glufosinate (white crystal, 38 g, yield: 87%, 97% ee).

Example 6

Under a nitrogen atmosphere, compound 1 (40.0 g, 242.4 mmol, 1.0 eq), 1,4-dioxane (64 g, 727.2 mmol, 3.0 eq) and triethylamine (29.4 g, 290.9 mmol, 1.2 eq) were respectively added to a three-neck flask, chloro(ethoxy)(methyl)phosphane (36.8 g, 290.9 mmol, 1.2 eq) was dropwise added, and the reaction was stirred at room temperature for 2 hours. The reaction was heated to 100° C., and allowed to proceed for 20 h. MS detection indicated that the raw material disappeared. The reaction was cooled to room temperature, dropwise added with 36% HCl (294.9 mL, 3432.6 mmol, 14.0 eq), and heated to reflux until complete reaction of the starting material. The solvent was evaporated, 95% ethanol (200 mL) and water (20 mL) were added, and the mixture was heated to reflux until the product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain L-glufosinate (white crystal, 36.2 g, yield: 83%, 97% ee).

Example 7

Under a nitrogen atmosphere, dichloro(methyl)phosphane (520.5 mmol, 0.6 eq, purity: 90%) was added to a round-bottom flask at room temperature (20° C.), diethyl methylphosphonite (1735 mmol, 2.0 eq, purity: 98%) was dropwise added through a constant-pressure funnel, and the reaction was continuously stirred for 10 minutes after the dropwise addition. A solution of compound 1 (867.5 mmol, 1.0 eq, purity: 96%, ee value: 99%) and triethylamine (107.5 g, 1041 mmol, 1.2 eq, purity: 98%) in 1,4-dioxane (500 g) was dropwise added, and the reaction was continuously stirred for 1.5 hours after the dropwise addition. The reaction solution was then heated to 90° C., and allowed to proceed for 20 h. The reaction solution was cooled to room temperature, and filtered with suction, the filter cake was washed with 1,4-dioxane (150 mL*3), and the filtrate was rotary evaporated to remove 1,4-dioxane. The reaction was added with 100 mL of concentrated hydrochloric acid (36%), heated to 90° C., and allowed to proceed for 10 hours. The solvent was rotary evaporated to dryness, 200 mL of concentrated hydrochloric acid (36%) was supplemented, and the reaction was continued at 90° C. for 10 hours. MS detection indicated the intermediate disappeared, and analysis of the reaction solution at this time indicated that the enantiomeric excess percentage (% ee) of L-glufosinate in the reaction solution was 92%. The reaction solution was cooled to room temperature, rotary evaporated to remove the solvent, added with 95% ethanol (300 mL), and heated to reflux until the crude product was completely dissolved. The mixture was cooled and crystallized, filtered, and dried to obtain the compound of L-glufosinate (yield: 69%, 97% ee).
In addition to those described herein, according to the foregoing description, various modifications to the present invention would be apparent to those skilled in the art. Such modifications are intended to fall within the scope of the appended claims. Each reference cited herein (including all patents, patent applications, journal articles, books and any other disclosures) are incorporated herein by reference in its entirety.

Claims

What is claimed is:

1. A mixture comprising:

one or more compounds of formula (IV) and one or more compounds of formula (III);

one or more compounds of formula (V) and one or more compounds of formula (III); or

one or more compounds of formula (III), one or more compounds of formula (IV) and one or more compounds of formula (V),

wherein:

Hal²is a halogen, and R₂, R₃and R₄are each independently alkyl, phenyl or substituted phenyl, and when the mixture comprises one or more compounds of the formula (IV) and one or more compounds of the formula (III), or when the mixture comprises one or more compounds of the formula (III), one or more compounds of the formula (IV) and one or more compounds of the formula (V), R₂is either R₃or R₄, provided that none of R₂, R₃and R₄is methyl.

2. The mixture according to claim 1, wherein Hal²is a chlorine atom.

3. The mixture according to claim 1, wherein R₂, R₃and R₄are each independently C₁-C₆alkyl, phenyl or substituted phenyl.

4. The mixture according to claim 1, wherein R₂, R₃and R₄are each independently ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl, pentyl, phenyl or substituted phenyl.

5. The mixture according to claim 1, wherein R₂, R₃and R₄are each independently ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl or pentyl.

6. The mixture according to claim 1, wherein R₂, R₃and R₄are each independently ethyl.

7. The mixture according to claim 1, wherein the compound of the formula (IV) is diethyl methylphosphonite, and the compound of the formula (V) is dichloro(methyl)phosphane.

8. A mixture comprising:

one or more compounds of the formula (IV) and one or more compounds of the formula (III), and a molar ratio of the compounds of formula (IV) to the compounds of the formula (III) is (0.9-1.1):1 or (0.05-1.1):1; or

one or more compounds of the formula (V) and one or more compounds of the formula (III), and a molar ratio of the compounds of the formula (V) to the compounds of the formula (III) is (0.9-1.1):1 or (0.05-1.1):1;

wherein:

Hal²is a halogen, and R₂, R₃and R₄are each independently alkyl, phenyl or substituted phenyl, and when the mixture comprises one or more compounds of the formula (IV) and one or more compounds of the formula (III), or when the mixture comprises one or more compounds of the formula (III), one or more compounds of the formula (IV) and one or more compounds of the formula (V), R₂is either R₃or R₄.

9. The mixture according to claim 8, wherein Hal²is a chlorine atom.

10. The mixture according to claim 8, wherein R₂, R₃and R₄are each independently C₁-C₆alkyl, phenyl or substituted phenyl.

11. The mixture according to claim 8, wherein R₂, R₃and R₄are each independently ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl, pentyl, phenyl or substituted phenyl.

12. The mixture according to claim 8, wherein R₂, R₃and R₄are each independently ethyl, propyl, 2-propyl, n-butyl, isobutyl, tert-butyl or pentyl.

13. The mixture according to claim 8, wherein R₂, R₃and R₄are each independently ethyl.

14. The mixture according to claim 8, wherein the compound of the formula (IV) is diethyl methylphosphonite, and the compound of the formula (V) is dichloro(methyl)phosphane.

15. The mixture according to claim 8, wherein the compound of the formula (IV) is diethyl methylphosphonite, and the compound of the formula (V) is dichloro(methyl)phosphane.

16. A method for the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof, wherein the method comprises a step of using the compound of formula (III):

wherein Hal²and R₂are as defined in claim 1.

17. A method for the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof, wherein the method comprises a step of using a compound of formula (IIIa):

18. A method for the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof, wherein the method comprises a step of using the mixture according to claim 1.

19. A method for the preparation of glufosinate or a salt thereof, or L-glufosinate or a salt thereof, wherein the method comprises a step of using the mixture according to claim 8.